Leapcure Acquires Honeybee Trials: Enhancing Patient Engagement and Research Site Solutions
Acquiring Company
Leapcure
Acquired Company
Honeybee Trials
Redwood CityBiotechnologyHealth CareMedicalPharmaceuticalBiotechnologyHealth CareDescription
Leapcure, a global leader in clinical trial solutions, has proudly announced the strategic acquisition of Honeybee Trials. This acquisition strengthens Leapcure's commitment to creating empathetic clinical trials that prioritize fairness, accessibility, and the inclusion of diverse patient experiences and enhances patient engagement and research site solutions.
Who to call at Leapcure, and when
When Leapcure changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Leapcure raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Leapcure, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Leapcure. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Leapcure makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Honeybee Trials?
Honeybee Trials was acquired by Leapcure, based in Redwood City. The deal was reported on August 13, 2024. Leapcure is a global leader in EQuitable clinical trial solutions, specializing in data-driven, tech-enabled patient recruitment. Leapcure is privately held and operates in Biotechnology.
When did Leapcure acquire Honeybee Trials?
Leapcure's acquisition of Honeybee Trials was reported on August 13, 2024. Leapcure, a global leader in clinical trial solutions, has proudly announced the strategic acquisition of Honeybee Trials. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Honeybee Trials do?
Honeybee Trials provides digital tools to source, identify, and screen patients for clinical trials. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.